P Kalpana Murthy
Overview
Explore the profile of P Kalpana Murthy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verma S, Joseph S, Verma R, Kushwaha V, Parmar N, Yadav P, et al.
Vaccine
. 2020 Jun;
38(32):5076.
PMID: 32517851
No abstract available.
2.
Kushwaha V, Sahasrabuddhe A, Murthy P
Acta Parasitol
. 2020 Jun;
65(4):990-994.
PMID: 32500507
Purpose: We recently identified disorganized muscle protein-1 of Brugia malayi (DIM-1bm) as a vaccine candidate for human lymphatic filariasis. The present study was aimed at investigating the localization of DIM-1bm...
3.
Kushwaha V, Tewari P, Mandal P, Tripathi A, Murthy P
Parasitol Res
. 2019 May;
118(6):1849-1863.
PMID: 31055672
In the search for immunoprophylactics for the control of human lymphatic filariasis, we recently identified troponin 1 (Tn1) in Brugia malayi adult worms. The present study reports the cloning and...
4.
Verma S, Arora A, Murthy P
Vaccine
. 2017 Aug;
35(38):5201-5208.
PMID: 28789852
In the search for potential vaccine candidates for the control of human lymphatic filariasis, we recently identified calponin-like protein, that regulates actin/myosin interactions, in a proinflammatory fraction F8 (45.24-48.64kDa) of...
5.
Kushwaha V, Saxena K, Verma R, Verma S, Katoch D, Kumar N, et al.
Parasit Vectors
. 2017 Apr;
10(1):208.
PMID: 28446204
No abstract available.
6.
Kushwaha V, Saxena K, Verma R, Verma S, Katoch D, Kumar N, et al.
Parasit Vectors
. 2016 Jun;
9(1):312.
PMID: 27245322
Background: Lymphatic filariasis caused by Wuchereria bancrofti, Brugia malayi and B. timori, is a debilitating disease with an adverse social and economic impact. The infection remains unabated in spite of...
7.
Verma S, Joseph S, Verma R, Kushwaha V, Parmar N, Yadav P, et al.
Vaccine
. 2014 Dec;
33(4):527-34.
PMID: 25454090
Nitric oxide (NO) mediated mechanisms have been implicated in killing of some life-stages of Brugia malayi/Wuchereria bancrofti and protect the host through type 1 responses and IFN-γ stimulated toxic mediators'...
8.
Yadav D, Kushwaha V, Saxena K, Verma R, Murthy P, Gupta M
Acta Trop
. 2013 Aug;
128(3):509-17.
PMID: 23911333
A large number of medicinal plants remain to be explored for antifilarial compounds. In the present study a crude methanolic extract of leaves of Alnus nepalensis, chloroform- and n-butanol-partitioned fractions...
9.
Saini V, Verma S, Murthy P, Kohli D
Vaccine
. 2013 Jul;
31(38):4183-91.
PMID: 23827312
Recently we identified in Brugia malayi adult worm extract (BmA) a pro-inflammatory 54-68kDa SDS-PAGE resolved fraction F6 that protects the host from the parasite via Th1/Th2 type responses. We are...
10.
Joseph S, Verma S, Verma R, Saxena J, Srivastava M, Murthy P
Acta Trop
. 2013 Apr;
127(2):82-6.
PMID: 23603670
We recently reported that BmAFI, an anti-inflammatory fraction of Brugia malayi adult worm supports parasite development in the hostile peritoneal cavity (p.c.) of Mastomys coucha through a modified Th2 type...